Remifentanil Requirement in Patients Receiving Surgical Treatment of Parkinson's Disease
NCT ID: NCT01992692
Last Updated: 2013-11-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
62 participants
OBSERVATIONAL
2012-01-31
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Requirement of Propofol for Induction of Unconsciousness in Patients With Parkinson's Disease
NCT01998204
Study for Perioperative Neurocognitive Disorders After Deep Brain Stimulation Surgery for Parkinson's Disease
NCT04696978
Treatment of Perioperative Neurocognitive Disorders With Olfactory Enrichment
NCT06488807
The National Registry Study For the Real-world Patients With Parkinsonian Disorders in China
NCT03649503
Motor Skill Learning in People With Parkinson's Disease
NCT00396942
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PD group
Parkinsonian patients undergoing deep brain stimulator insertion and pulse generator placement
No interventions assigned to this group
non-PD group
Non-Parkinsonian patients undergoing intracranial surgery
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult non-Parkinsonian patients undergoing intracranial surgery
Exclusion Criteria
* predicted difficult airway
* alcohol or drug abuser
* informed consent was not provided
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Changhai Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jia-feng Wang
Dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Anesthesiology, Changhai Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wang JF, Xu XP, Yu XY, Li JB, Wu X, Chen JC, Hu XW, Deng XM. Remifentanil Requirement for Inhibiting Responses to Tracheal Intubation and Skin Incision Is Reduced in Patients With Parkinson's Disease Undergoing Deep Brain Stimulator Implantation. J Neurosurg Anesthesiol. 2016 Oct;28(4):303-8. doi: 10.1097/ANA.0000000000000229.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Parkinson-remifentanil
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.